日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern

SARS-CoV2 变体特异性复制 RNA 疫苗可在受到令人担忧的异源变体攻击后预防疾病

David W Hawman, Kimberly Meade-White, Jacob Archer, Shanna S Leventhal, Drew Wilson, Carl Shaia, Samantha Randall, Amit P Khandhar, Kyle Krieger, Tien-Ying Hsiang, Michael Gale, Peter Berglund, Deborah Heydenburg Fuller, Heinz Feldmann, Jesse H Erasmus

Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device

利用并行微流控装置实现可扩展的mRNA和siRNA脂质纳米颗粒生产

Shepherd, Sarah J; Warzecha, Claude C; Yadavali, Sagar; El-Mayta, Rakan; Alameh, Mohamad-Gabriel; Wang, Lili; Weissman, Drew; Wilson, James M; Issadore, David; Mitchell, Michael J

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern

SARS-CoV2 变体特异性复制型 RNA 疫苗可预防疾病和病理,并减少受到令人担忧的异源 SARS-CoV2 变体攻击后的病毒脱落

David W Hawman, Kimberly Meade-White, Jacob Archer, Shanna Leventhal, Drew Wilson, Carl Shaia, Samantha Randall, Amit P Khandhar, Tien-Ying Hsiang, Michael Gale Jr, Peter Berglund, Deborah Heydenburg Fuller, Heinz Feldmann, Jesse H Erasmus